NYSE - Delayed Quote USD

Medifast, Inc. (MED)

13.41
-0.04
(-0.30%)
At close: May 23 at 4:00:02 PM EDT
13.41
0.00
(0.00%)
After hours: May 23 at 4:09:01 PM EDT
Loading Chart for MED
  • Previous Close 13.45
  • Open 13.21
  • Bid 13.38 x 800
  • Ask 13.42 x 800
  • Day's Range 13.04 - 13.45
  • 52 Week Range 11.57 - 26.53
  • Volume 150,496
  • Avg. Volume 223,536
  • Market Cap (intraday) 147.389M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) --
  • EPS (TTM) -0.64
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est 15.00

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

medifastinc.com

504

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MED

View More

Performance Overview: MED

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MED
23.89%
S&P 500 (^GSPC)
1.34%

1-Year Return

MED
41.08%
S&P 500 (^GSPC)
10.16%

3-Year Return

MED
91.18%
S&P 500 (^GSPC)
46.03%

5-Year Return

MED
83.00%
S&P 500 (^GSPC)
96.34%

Compare To: MED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MED

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    147.39M

  • Enterprise Value

    -2.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.70

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.29%

  • Return on Assets (ttm)

    1.33%

  • Return on Equity (ttm)

    -3.32%

  • Revenue (ttm)

    543.45M

  • Net Income Avi to Common (ttm)

    -7M

  • Diluted EPS (ttm)

    -0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    164.59M

  • Total Debt/Equity (mrq)

    6.93%

  • Levered Free Cash Flow (ttm)

    14.01M

Research Analysis: MED

View More

Company Insights: MED

Research Reports: MED

View More

People Also Watch